Humby, F., Durez, P., Buch, M., Lewis, M., Bombardieri, M., John, C., . . . Pitzalis, C. (2022). Rituximab versus tocilizumab and B-cell status in TNF-alpha inadequate-responder rheumatoid arthritis patients: The R4-RA RCT. NIHR Journals Library.
Style de citation Chicago (17e éd.)Humby, F., et al. Rituximab Versus Tocilizumab and B-cell Status in TNF-alpha Inadequate-responder Rheumatoid Arthritis Patients: The R4-RA RCT. NIHR Journals Library, 2022.
Style de citation MLA (9e éd.)Humby, F., et al. Rituximab Versus Tocilizumab and B-cell Status in TNF-alpha Inadequate-responder Rheumatoid Arthritis Patients: The R4-RA RCT. NIHR Journals Library, 2022.
Attention : ces citations peuvent ne pas être correctes à 100%.